Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

RUBIS: First CDP rating for Rubis: the Group obtains B grade
RUBIS: First CDP rating for Rubis: the Group obtains B grade
RUBIS: First CDP rating for Rubis: the Group obtains B grade
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
DGAP-News: Abivax erhält Feedback der US-Amerikanischen Zulassungsbehörde mit Guidance zur Überführung von ABX464 in die klinische Phase-3-Testung
DGAP-News: Abivax erhält Feedback der US-Amerikanischen Zulassungsbehörde mit Guidance zur Überführung von ABX464 in die klinische Phase-3-Testung
DGAP-News: Abivax erhält Feedback der US-Amerikanischen Zulassungsbehörde mit Guidance zur Überführung von ABX464 in die klinische Phase-3-Testung
DGAP-News: Abivax receives FDA feedback with guidance on advancing ABX464 into phase 3 clinical testing in ulcerative colitis
DGAP-News: Abivax receives FDA feedback with guidance on advancing ABX464 into phase 3 clinical testing in ulcerative colitis
DGAP-News: Abivax receives FDA feedback with guidance on advancing ABX464 into phase 3 clinical testing in ulcerative colitis
DGAP-News: Abivax' Phase-1/2-Studienergebnisse mit ABX196 zur Behandlung von Leberkrebs zeigen gute Sicherheit und vielversprechende Anzeichen klinischen Nutzens ...
DGAP-News: Abivax' Phase-1/2-Studienergebnisse mit ABX196 zur Behandlung von Leberkrebs zeigen gute Sicherheit und vielversprechende Anzeichen klinischen Nutzens ...
DGAP-News: Abivax' Phase-1/2-Studienergebnisse mit ABX196 zur Behandlung von Leberkrebs zeigen gute Sicherheit und vielversprechende Anzeichen klinischen Nutzens ...
DGAP-News: Abivax's phase 1/2 clinical study results of ABX196 in liver cancer show good tolerability and promising signals of clinical benefit and were selected for presentation at the ASCO GI Cancers Symposium
DGAP-News: Abivax's phase 1/2 clinical study results of ABX196 in liver cancer show good tolerability and promising signals of clinical benefit and were selected for presentation at the ASCO GI Cancers Symposium
DGAP-News: Abivax's phase 1/2 clinical study results of ABX196 in liver cancer show good tolerability and promising signals of clinical benefit and were selected for presentation at the ASCO GI Cancers Symposium
BILENDI: Bilendi announces the completion of the the acquisition of the respondi group
BILENDI: Bilendi announces the completion of the the acquisition of the respondi group
BILENDI: Bilendi announces the completion of the the acquisition of the respondi group
Pharnext appoints Dr. Burkhard Blank as new Chief Medical Officer and Head of Research & Development
Pharnext appoints Dr. Burkhard Blank as new Chief Medical Officer and Head of Research & Development
Pharnext appoints Dr. Burkhard Blank as new Chief Medical Officer and Head of Research & Development
Freelance.com: Organic growth in Q3 2021: +32%. Positive trend across all the Group's activities
Freelance.com: Organic growth in Q3 2021: +32%. Positive trend across all the Group's activities
Freelance.com: Organic growth in Q3 2021: +32%. Positive trend across all the Group's activities
BILENDI: Bilendi acquires the respondi Group,  a European player in data collection for market research
BILENDI: Bilendi acquires the respondi Group, a European player in data collection for market research
BILENDI: Bilendi acquires the respondi Group, a European player in data collection for market research
CarMax’s Impressive Rally: What Investors Should Watch Next: https://www.marketbeat.com/logos/articles/med_20240927115110_carmaxs-impressive-rally-what-investors-should-wat.jpg
CarMax’s Impressive Rally: What Investors Should Watch Next

Shares of CarMax Inc. (NYSE: KMX) jumped by over 15.3% in a single day following the company’s latest quarterly earnings release. Investors in the know are already aware of what is happening to

Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value: https://www.marketbeat.com/logos/articles/med_20240925091256_bausch-health-a-buyout-bid-could-be-the-ticket-to.jpg
Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value

Bausch Health (NYSE: BHC) stock has been on a wild ride recently, with a dramatic surge in value over the last month. The catalyst for this surge is a wave of rumors suggesting that Bausch +

Williams Sonoma Stock Could Be Ripe for a Short at Current Levels: https://www.marketbeat.com/logos/articles/med_20240923134358_williams-sonoma-stock-could-be-ripe-for-a-short-at.jpg
Williams Sonoma Stock Could Be Ripe for a Short at Current Levels

Investors can save a lot of money and even boost their potential returns when they realize that there is one major difference between a stock and a business. Apple Inc. (NASDAQ: AAPL) might be an

2 Avocado Stocks Proving the Superfood Can Be a Super Investment: https://www.marketbeat.com/logos/articles/med_20240917142044_2-avocado-stocks-proving-the-superfood-can-be-a-su.jpg
2 Avocado Stocks Proving the Superfood Can Be a Super Investment

Rich in antioxidants like Omega 3, magnesium, potassium, fiber, and lutein, as well as nutrients, including vitamins A through E and K, the avocado is a superfood (and a fruit). Last year, the

Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge: https://www.marketbeat.com/logos/articles/med_20240917091551_gold-hits-new-all-time-highs-3-stocks-to-ride-the.jpg
Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge

Gold has surged to a new all-time high, rising 33.5% over the past year to $2,583.64/oz. This is driven by easing inflation and expectations that the Federal Reserve will cut interest rates after

What Buybacks and Lower Rates Could Mean for Restaurant Brands: https://www.marketbeat.com/logos/articles/med_20240917083614_what-buybacks-and-lower-rates-could-mean-for-resta.jpg
What Buybacks and Lower Rates Could Mean for Restaurant Brands

Restaurant Brands (NYSE: QSR) owns massive fast-food chains like Burger King, Popeyes, and Tim Hortons. The company has received approval for its share buyback program, under which it will be able

Silver’s Breakout: 3 Momentum Stocks You Can’t Miss: https://www.marketbeat.com/logos/articles/med_20240916141404_3-momentum-stocks-to-watch-as-silver-prices-break.jpg
Silver’s Breakout: 3 Momentum Stocks You Can’t Miss

The global financial cycle has a few tail ends, and the two are typically divided between stocks and commodities. When one performs, the other tends to underperform, with currency performance in

Rate Cuts or Not, These 3 Stocks Are Poised to Outperform: https://www.marketbeat.com/logos/articles/med_20240916172108_rate-cuts-or-not-these-3-stocks-are-poised-to-outp.jpg
Rate Cuts or Not, These 3 Stocks Are Poised to Outperform

Investors are on edge as the Federal Reserve prepares to make its next interest rate decision. While some scramble for cover, seasoned investors seek opportunities in companies poised to weather

Why Zillow Group Could Soar with the Upcoming Interest Rate Cuts: https://www.marketbeat.com/logos/articles/med_20240915183935_chatt-zg.jpg
Why Zillow Group Could Soar with the Upcoming Interest Rate Cuts

Real estate brokers and online real estate marketplace stocks are surging in anticipation of the Federal Reserve interest rate cut cycle commencing, and investors are paying attention.

Among the

RH’s Transformation Pay Off Will Accelerate with Rate Cuts: https://www.marketbeat.com/logos/articles/med_20240915184853_chartw-rh.jpg
RH’s Transformation Pay Off Will Accelerate with Rate Cuts

Formerly known as Restoration Hardware, RH (NYSE: RH) is a high-end home furnishings retailer offering curated collections of luxury furniture, decor, bathware and textiles. Its stock surged 25%

3 Defensive Stock Alternatives to Bonds If Interest Rates Drop: https://www.marketbeat.com/logos/articles/med_20240913133242_3-defensive-stock-alternatives-to-bonds-if-interes.jpg
3 Defensive Stock Alternatives to Bonds If Interest Rates Drop

Bonds play a central role in the investment strategies of many defensive or conservative investors. The price of bonds shifts in an inverse fashion compared to yields, meaning that as the Federal

Can Celsius Stock Rebound? Analysts See 74% Upside Potential: https://www.marketbeat.com/logos/articles/med_20240913111124_can-celsius-stock-rebound-analysts-see-74-upside-p.jpg
Can Celsius Stock Rebound? Analysts See 74% Upside Potential

Celsius Holdings, Inc. (NASDAQ: CELH) is the maker of the popular Celsius energy drink, formulated to power active lifestyles with its unique blend of essential vitamins. Celsius’s line of

3 Stocks That Could See Rising Demand Based on Latest Jobs Data: https://www.marketbeat.com/logos/articles/med_20240912084137_3-stocks-that-could-see-rising-demand-based-on-lat.jpg
3 Stocks That Could See Rising Demand Based on Latest Jobs Data

Looking into jobs data isn’t just useful for understanding how strong the general economy is. It can also provide insight into what types of companies might be preparing for increases in the

3 Key Reasons Why Rocket Companies Stock Will Rally Soon: https://www.marketbeat.com/logos/articles/med_20240911111854_3-key-reasons-why-rocket-companies-stock-will-rall.jpg
3 Key Reasons Why Rocket Companies Stock Will Rally Soon

Markets will always have a reason to keep the market going, and always come up with reasons as to why a stock might be falling, whether these reasons are valid or not. Today, investors need to cut

Verint Systems' AI Bots Revolutionize Customer Service Efficiency: https://www.marketbeat.com/logos/articles/med_20240908180437_chartw-vrnt.jpg
Verint Systems' AI Bots Revolutionize Customer Service Efficiency

When you call a customer service line and are greeted with an automated voice system that attempts to confirm your identity and inquire about your issue, you may be engaging with an artificial